As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: November 18, 2014
The battle against Alzheimer’s disease could be heading in a new direction following the announcement of a new blood test.
Researchers at the National Institute of Aging say their new blood test can predict Alzheimer’s up to 10 years before the onset of symptoms. This is the third blood test announced this year that finds Alzheimer’s, which is normally diagnosed based on cognitive symptoms.
But, would you really want to know? There is no treatment for Alzheimer’s Disease. Unlike AIDS or HIV early detection means nothing since there is no treatment at any stage. So would you really want to know you will develop Alzheimer’s Disease in five or ten years?
Chief of Neurology at Kelsey-Seybold Dr. Jonathan Garza says the new method for testing is exciting, “We’re still trying to figure out what these proteins really mean and if whether they are a by-product of this dysfunction or if they are a contributory agent.”
The blood test looks for the protein ISR-1, or insulin resistance receptor. The latest science is providing a link between Alzheimer’s Disease and diabetes. But, not all diabetics develop Alzheimer’s and not all Alzheimer’s patients are diabetics.
The new blood test is still in the trial phase and so far has only been tested on 174 individuals. It did correctly diagnose every single individual, leading to the claim by the researchers that the test if 100% accurate.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.